Using Cardiac Magnetic Resonance Imaging to Assess Risk in Patients with Dilated Cardiomyopathy

What this Trial Is About

Dilated cardiomyopathy DCM is a serious heart condition marked by weakened heart muscle and enlarged heart chambers, leading to risks such as sudden cardiac death or advanced heart failure. Researchers are studying the use of cardiac magnetic resonance CMR, a detailed imaging method that measures heart mass, volume, and function, to better assess risk and diagnose DCM. This observational study aims to understand how CMR can help in predicting outcomes for people with DCM over a long-term period. Participants will undergo cardiac magnetic resonance imaging to evaluate heart structure and function. The study does not involve experimental treatments but focuses on monitoring patients with DCM using CMR. The study will track outcomes such as all-cause mortality, sudden cardiac death, heart failure worsening, and major adverse cardiac events over a period of 1 to 10 years. During the study, participants will be followed up regularly to assess their health status and heart function using CMR and other clinical evaluations. Researchers will collect data on mortality and cardiac events to analyze risk factors linked to DCM. This long-term observation will help improve understanding of disease progression and potential risk stratification in patients with DCM.

Cardiac Magnetic Resonance for Risk Stratification in Dilated Cardiomyopathy